Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Sugar and Gold Forms Basis for Fast Specific Flu Test

Published: Monday, December 09, 2013
Last Updated: Monday, December 09, 2013
Bookmark and Share
A new approach to influenza testing, that utilises sugar labelled with gold to distinguish between human and avian strains, has been patented by researchers on Norwich Research Park.

If the flu virus is detected, the rich red of the gold solution will change colour, creating a quick and simple technique that has the potential for use worldwide with minimal training.

The team is a collaboration led by Professor Rob Field of the John Innes Centre and Professor David Russell of University of East Anglia. Prof Russell has already founded a spinout company – Intelligent Fingerprinting that detects drugs and drug metabolites in fingerprints – to exploit his previous work on optically based molecular recognition systems.

Professor Field explains that 90% of infections use carbohydrate recognition to bind with their targets in the human body and this process can be used as a basis for sensor development.  He says the same basic principles can be applied wherever rapid detection is required from detecting superbugs in hospitals to biohazards such as ricin.

“We have already developed a carbohydrate-based sensor to detect cholera in contaminated water supplies. The sensor is a suspension of sugars tagged with inexpensive gold nanoparticles.  If cholera is present it will attach to the sugar pulling the particles closer together.  This creates a change in the photophysics of the suspension, resulting in a colour change that is visible to the naked eye.

“We are now applying these principles to influenza.  We have found that different types of flu virus have different sugar binding capabilities, so it is therefore possible to use a colour change not only to identify the presence and absence of the virus but also to distinguish between them.”

On the surface of the human cell are sugar chains containing a molecule called sialic acid. Researchers have found that human flu and avian flu both have receptors for sialic acid but with a preference for different sugar chains. This can be used to differentiate between the flu virus strains.

Professor Russell explained that the new assay based on gold nanoparticles is much faster than current methods of detection.

“Preventing a new influenza pandemic requires both vaccination and antiviral drugs administered within 48 hours of the infection. Current methods of detection require isolation and culture of the virus and may take several hours or even days to get the results; which can be too long for the patient.  It is clear that a rapid, diagnostic test that is able to discriminate between the different strains of virus is essential.”

Results recently published in Organic & Biomolecular Chemistry* showed that functionalized gold nanoparticles were able to detect the human influenza virus X31 (H3N2) within 30 minutes and it was able to distinguish between human and avian influenza, which is exceptionally important.   This provides proof of concept for this innovative bioassay, which has potential for the specific recognition and detection of influenza virus strains in clinical samples.

Professor Field says the low-tech approach makes it a quick and easy dipstick test that can be used in the field with little training.

After successfully patenting the technique the researchers are now looking for a diagnostics company to partner with to bring it to market.

* Paper reference:  Org. Biomol. Chem., 2013,11, 7101-7107 DOI: 10.1039/C3OB41703D


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
New Strategy for Combating Adenoviruses
Using an animal model they developed, Saint Louis University and Utah State university researchers have identified a strategy that could keep a common group of viruses called adenoviruses from replicating and causing sickness in humans.
Major Advance Toward More Effective, Long-Lasting Flu Vaccine
Collaboration shows vaccine candidate can produce powerful ‘broadly neutralizing antibodies’ in animal models.
Immune System: Help for Killer Cells
A study from the University of Bonn may show the way to more effective vaccines.
Protein Found to Control Inflammatory Response
A new Northwestern Medicine study shows that a protein called POP1 prevents severe inflammation and, potentially, diseases caused by excessive inflammatory responses.
A Leap Forward in Vaccinating Against HIV
A team of scientists has developed an experimental vaccine candidate that successfully stimulates the immune system activity in animal models necessary to stop HIV infection.
MRI Scanners Can Steer Therapeutics to Specific Target Sites
Scientists from the University of Sheffield have discovered MRI scanners, normally used to produce images, can steer cell-based, tumour busting therapies to specific target sites in the body.
Agricultural Intervention Improves HIV Outcomes
A multifaceted farming intervention can reduce food insecurity while improving HIV outcomes in patients in Kenya, according to a randomized, controlled trial led by researchers at UC San Francisco.
Team Finds Early Inflammatory Response Paralyzes T Cells
Findings could have enormous implications for immunotherapy, autoimmune disorders, transplants and other aspects of immunity.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!